A corporate investor at Johnson & Johnson shares the company's venture investment philosophy at a time of change in healthcare.
Renee Ryan is the vice president of investments at JJDC, the venture arm of Johnson & Johnson. She will be a speaker on the funding panel at MEDevice San Diego, Sept. 2, an event hosted by UBM, which publishes MD+DI.
Recently, in a phone interview, she described JJDC's investing philosophy, what she looks for in device firms and her excitement when she comes across a promising device startup, with cool new technology and headed by a female CEO.
MD+DI: How has JJDC evolved...